Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Thyroid”

1,276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,276 results

Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Not applicableUnknownNCT06241092
What this trial is testing

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 256
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Ended earlyNCT00126568
What this trial is testing

Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerRecurrent Thyroid Cancer
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07239674
What this trial is testing

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Who this might be right for
Intermediate-to-High Risk Differentiated Thyroid Cancer
West China Hospital 646
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Testing effectiveness (Phase 2)Study completedNCT01013597
What this trial is testing

Trial of LBH589 in Metastatic Thyroid Cancer

Who this might be right for
Thyroid Carcinoma
University of Wisconsin, Madison 13
Not applicableStudy completedNCT02150772
What this trial is testing

The Diagnostic Value of Shear Wave Elastography

Who this might be right for
Thyroid Nodule
University of Aarhus 308
Not applicableLooking for participantsNCT07033572
What this trial is testing

Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma

Who this might be right for
Thyroid NeoplasmsCarcinoma, Papillary
Fujian Medical University 60
Testing effectiveness (Phase 2)Study completedNCT00098345
What this trial is testing

Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Genzyme, a Sanofi Company 40
Not applicableStudy completedNCT06391021
What this trial is testing

Comparison Between Combined Scoring of Bethesda Cytology and TIRADS Ultrasound With Histopathology in Thyroid Nodule

Who this might be right for
Thyroid Nodule
Tribhuvan University, Nepal 42
Large-scale testing (Phase 3)Active Not RecruitingNCT03570021
What this trial is testing

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Gustave Roussy, Cancer Campus, Grand Paris 352
Not applicableActive Not RecruitingNCT04467021
What this trial is testing

Cancer and Blood Pressure Management, CARISMA Study

Who this might be right for
Cardiovascular DisorderChronic Kidney DiseaseMetastatic Renal Cell Carcinoma+6 more
ECOG-ACRIN Cancer Research Group 61
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Not applicableEnded earlyNCT03986593
What this trial is testing

Cryoablation of Bone Metastases From Endocrine Tumors

Who this might be right for
Neoplasm MetastasisThyroid NeoplasmPheochromocytoma+3 more
Instituto do Cancer do Estado de São Paulo 17
Not applicableStudy completedNCT03787121
What this trial is testing

Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers

Who this might be right for
Thyroid Cancer
University Hospital, Toulouse 361
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Next Page